Second-line ARV access increased through Clinton, Pfizer and Mylan agreement
12 August 2009
Becky Debens
The prices of second-line treatments for HIV and tuberculosis in the developing world have been cut after an agreement was signed between the
Clinton Foundation's HIV/AIDS Initiative (CHAI),
Pfizerand
Mylan.
This is CHAI's first pricing agreement with an innovator company, as well as its first...
Please Login to read the full article.
12 August 2009
Becky Debens
This is CHAI's first pricing agreement with an innovator company, as well as its first...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: With wish granted, Collins forges ahead with new translational science centre
- US State Department chief says US stepping up HIV/AIDS efforts; challenges other nations
- UNITAID set to 'transition' out of CHAI projects
- Gilead's Truvada cut risk of HIV infection by up to 78% in heterosexuals
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
